News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
347,278 Results
Type
Article (10713)
Company Profile (26)
Press Release (336538)
Multimedia
Podcasts (19)
Webinars (12)
Section
Business (113260)
Career Advice (1941)
Deals (21345)
Drug Delivery (64)
Drug Development (30610)
Employer Resources (102)
FDA (7620)
Job Trends (7811)
News (174981)
Policy (12513)
Tag
2027 Pharm Country Standard (2)
Academia (837)
Academic (1)
Accelerated approval (13)
Adcomms (5)
Allergies (84)
Alliances (23041)
ALS (64)
Alzheimer's disease (694)
Antibody-drug conjugate (ADC) (120)
Approvals (7919)
Artificial intelligence (278)
Autoimmune disease (75)
Automation (16)
Bankruptcy (163)
Best Places to Work (6642)
BIOSECURE Act (6)
Biosimilars (118)
Biotechnology (24)
Bladder cancer (88)
Brain cancer (27)
Breast cancer (351)
Cancer (2403)
Cardiovascular disease (225)
Career advice (1601)
Career pathing (34)
CAR-T (105)
CDC (4)
Cell therapy (301)
Cervical cancer (20)
Clinical research (28199)
Collaboration (800)
Company closure (1)
Compensation (270)
Complete response letters (20)
COVID-19 (713)
CRISPR (23)
C-suite (519)
Cystic fibrosis (68)
Data (3433)
Decentralized trials (2)
Denatured (12)
Depression (71)
Diabetes (337)
Diagnostics (4094)
Digital health (38)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (99)
Drug pricing (91)
Drug shortages (13)
Duchenne muscular dystrophy (117)
Earnings (49688)
Editorial (24)
Employer branding (12)
Employer resources (99)
Events (54854)
Executive appointments (662)
FDA (9460)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (13)
Funding (861)
Gene editing (69)
Generative AI (17)
Gene therapy (228)
GLP-1 (537)
Government (1418)
Grass and pollen (3)
Guidances (342)
Healthcare (10467)
HIV (35)
Huntington's disease (14)
IgA nephropathy (40)
Immunology and inflammation (84)
Immuno-oncology (19)
Indications (70)
Infectious disease (817)
Inflammatory bowel disease (106)
Inflation Reduction Act (7)
Influenza (49)
Intellectual property (120)
Interviews (365)
IPO (11223)
IRA (20)
Job creations (1376)
Job search strategy (1325)
JPM (24)
Kidney cancer (12)
Labor market (37)
Layoffs (164)
Leadership (26)
Legal (2315)
Liver cancer (45)
Longevity (6)
Lung cancer (345)
Lymphoma (225)
Machine learning (18)
Management (45)
Manufacturing (376)
MASH (95)
Medical device (8220)
Medtech (8261)
Mergers & acquisitions (10922)
Metabolic disorders (784)
Multiple sclerosis (87)
NASH (7)
Neurodegenerative disease (126)
Neuropsychiatric disorders (35)
Neuroscience (1272)
Neurotech (1)
NextGen: Class of 2026 (3752)
Non-profit (1815)
Now hiring (51)
Obesity (336)
Opinion (125)
Ovarian cancer (67)
Pain (146)
Pancreatic cancer (106)
Parkinson's disease (133)
Partnered (25)
Patents (229)
Patient recruitment (228)
Peanut (38)
People (39315)
Pharmaceutical (11)
Pharmacy benefit managers (32)
Phase 1 (7976)
Phase 2 (12007)
Phase 3 (10183)
Pipeline (3275)
Policy (89)
Postmarket research (990)
Preclinical (2806)
Press Release (22)
Prostate cancer (129)
Psychedelics (10)
Radiopharmaceuticals (146)
Rare diseases (373)
Real estate (2637)
Recruiting (45)
Regulatory (10828)
Reports (15)
Research institute (831)
Resumes & cover letters (348)
Rett syndrome (24)
RNA editing (3)
RSV (24)
Schizophrenia (89)
Series A (168)
Series B (130)
Service/supplier (2)
Sickle cell disease (41)
Special edition (7)
Spinal muscular atrophy (76)
Sponsored (23)
Startups (2080)
State (1)
Stomach cancer (2)
Supply chain (59)
Tariffs (28)
The Weekly (7)
Vaccines (229)
Venture capital (54)
Weight loss (209)
Women's health (34)
Worklife (18)
Date
Today (96)
Last 7 days (328)
Last 30 days (1138)
Last 365 days (17489)
2026 (1834)
2025 (17736)
2024 (20537)
2023 (23206)
2022 (27714)
2021 (30194)
2020 (29009)
2019 (25520)
2018 (19103)
2017 (17140)
2016 (15397)
2015 (18310)
2014 (13215)
2013 (10159)
2012 (11051)
2011 (11442)
2010 (10068)
Location
Africa (412)
Alabama (55)
Alaska (4)
Arizona (139)
Arkansas (7)
Asia (20326)
Australia (3585)
California (6286)
Canada (2445)
China (568)
Colorado (263)
Connecticut (284)
Delaware (162)
Europe (45302)
Florida (1085)
Georgia (198)
Idaho (29)
Illinois (498)
India (40)
Indiana (392)
Iowa (11)
Japan (257)
Kansas (50)
Kentucky (10)
Louisiana (23)
Maine (52)
Maryland (727)
Massachusetts (4456)
Michigan (235)
Minnesota (385)
Mississippi (3)
Missouri (64)
Montana (17)
Nebraska (18)
Nevada (80)
New Hampshire (42)
New Jersey (2026)
New Mexico (17)
New York (1783)
North Carolina (863)
North Dakota (4)
Northern California (3105)
Ohio (166)
Oklahoma (5)
Oregon (13)
Pennsylvania (1340)
Puerto Rico (22)
Rhode Island (20)
South America (623)
South Carolina (31)
South Dakota (1)
Southern California (2480)
Tennessee (107)
Texas (1126)
United States (23186)
Utah (197)
Virginia (101)
Washington D.C. (46)
Washington State (475)
West Virginia (2)
Wisconsin (59)
Wyoming (1)
347,278 Results for "vakzine projekt management".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG
Vakzine Projekt Management GmbH announced the successful completion of a clinical client project for Memo Therapeutics AG, Switzerland.
January 25, 2023
·
5 min read
VPM contributes to the successful licensure of the novel malaria vaccine R21/Matrix-MTM for first use in Ghana
Vakzine Projekt Management GmbH (VPM) is delighted to announce the successful licensing of the novel R21/Matrix-MTM Malaria Vaccine by the Ghana Food and Drugs Authority (FDA) for use in children as young as 5 months old up to 36 months old, in Ghana.
May 10, 2023
·
6 min read
Press Releases
Changes to the Executive Management
December 12, 2025
·
2 min read
Press Releases
Managers’ transactions
November 24, 2025
·
7 min read
Press Releases
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
February 12, 2026
·
4 min read
Press Releases
GE HealthCare management to present at upcoming investor conferences - February 12, 2026
February 12, 2026
·
1 min read
Press Releases
BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer
January 29, 2026
·
6 min read
Press Releases
Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards
January 29, 2026
·
1 min read
Press Releases
Apyron Pioneering Next Generation Pain Management Solutions
December 15, 2025
·
2 min read
Press Releases
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
February 12, 2026
·
5 min read
1 of 34,728
Next
